CONSULTANTS AND RESEARCHERS

LAURE STORCK

Head of Research

Laure has a Master’s Degree in Human Resources from IGS Paris, a Postgraduate Diploma in German from the University of Strasbourg and is also qualified as an accountant (DECF).
Prior to joining the Virdis Group Laure worked in human resources and training within Sanofi and GlaxoSmithKline in France.  She moved to the UK in 2008 where she leads the Virdis Group research team.
Laure is an experienced and active executive search consultant for several of our long-established international pharmaceutical  and medical device clients.

OLGA LASCANO

Olga is multilingual, originally from Colombia, and with an academic background in Clinical & Health Psychology from the University of Mainz, in Germany.

She has experience in academic recruitment and media analysis prior to joining the Virdis Group research and consultancy team in 2012.

Olga has particular expertise in medical affairs, market access and animal health roles.

JOHN SIMMONS

John brings over 30 years of client-side business experience and a formidable network within the pharmaceutical industry.  Prior to joining the Virdis Group John was most recently a Group Director at Pfizer International; and he understands the business pressures which drive our clients’ expectations for high quality executive search.

John has a degree in Zoology and a Master’s degree in Parasitology; he is a Fellow of the Institute of Direct Marketing, a Business Leader in the Marketing Society and a member of the Chartered Institute of Marketing.

His experience includes senior roles in human pharma, animal health and consumer healthcare where he led international change programmes, acquisitions, divestments, a dozen product launches, clinical research programmes and customer facing teams of all sizes.

TONY SEDGWICK

Associate

Tony is an experienced entrepreneurial executive.  He has held various senior leadership positions in Research and Development, becoming World-Wide Head of Clinical Operations for Roche. His product successes include Invirase and Tamiflu which have had significant impact both medically and commercially.

Tony has been Chief Executive Officer of four biotechnology companies, with two of them successfully exited.  He has also been chairman of a number of European and British Biotechnology companies .

During the last few years Tony has specialised in ‘trusted’ advisory roles for CEOs and heads of R&D.  He has a deep belief that people are the key to the fast-moving technology space.  The human, not the machine part, will  be unique selling point for business in the future, where innovation and creativity is key.  Click to go to his suitably-named blog site: The Thought Disruptor.